Production (Stage)
ProKidney Corp.
PROK
$0.9776
$0.190624.22%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 306.00K | 76.00K | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 306.00K | 76.00K | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 306.00K | 76.00K | -- | -- | -- |
| SG&A Expenses | 52.27M | 50.76M | 40.58M | 42.60M | 42.40M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 179.97M | 178.43M | 150.99M | 153.96M | 150.72M |
| Operating Income | -179.66M | -178.35M | -150.99M | -153.96M | -150.72M |
| Income Before Tax | -166.06M | -163.93M | -136.09M | -133.77M | -129.10M |
| Income Tax Expenses | -105.00K | -598.00K | 491.00K | 3.75M | 4.77M |
| Earnings from Continuing Operations | -165.95 | -163.34 | -136.58 | -137.51 | -133.87 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 97.53M | 102.15M | 90.97M | 98.83M | 98.58M |
| Net Income | -68.43M | -61.19M | -45.61M | -38.68M | -35.30M |
| EBIT | -179.66M | -178.35M | -150.99M | -153.96M | -150.72M |
| EBITDA | -173.73M | -172.92M | -145.99M | -149.44M | -146.60M |
| EPS Basic | -0.60 | -0.63 | -0.55 | -0.59 | -0.57 |
| Normalized Basic EPS | -0.01 | 0.07 | 0.15 | 0.24 | 0.29 |
| EPS Diluted | -0.60 | -0.63 | -0.55 | -0.59 | -0.57 |
| Normalized Diluted EPS | -0.01 | 0.07 | 0.15 | 0.24 | 0.29 |
| Average Basic Shares Outstanding | 459.27M | 391.24M | 325.19M | 260.61M | 249.27M |
| Average Diluted Shares Outstanding | 459.27M | 391.24M | 325.19M | 260.61M | 249.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |